共同支付券如何影响品牌药品价格和购买量?
Leemore Dafny1, Kate Ho2, Edward Kong3
1Harvard Business School and Harvard Kennedy School.
概括
药品共同支付优惠券将处方药的销售额提高高达25%. 这导致品牌药物没有仿制品替代品的净折扣价格上8%.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 市场分析市场分析
背景情况:
- 药品共同支付券可以减少患者的自付费用.
- 这些优惠券普遍用于品牌药物,但在医疗保险优惠中被禁止.
- 了解它们对市场的影响对于政策评估至关重要.
研究的目的:
- 估计药品共同支付券对药品定价和销售的因果关系.
- 分析商业保险和医疗保险优势之间的差异影响.
- 量化coupon可用性对平衡价的影响.
主要方法:
- 分析药品销售数据,比较带有和没有优惠券的细分市场.
- 对多发性硬化症药物的离散选择需求模型的估计.
- 模拟药品价格谈判模型,以评估平衡结果.
主要成果:
- 与医疗保险优势相比,在商业部门,引入优惠券增加了23-25%的销售量.
- 没有仿制药替代品的品牌药品的净折扣价格估计由于优惠券的可用性而高出8%.
- 观察到对需求和净价格的重大影响.
结论:
- 药品共同支付券大大提高了品牌药品的销售额.
- 优惠券的可用性导致较高的净折扣价格,影响市场动态.
- 需要考虑对药物定价和可访问性的政策影响.
相关概念视频
Drug Dosage Regimen: Overview
4.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.4K
Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Agonism and Antagonism: Quantification
975
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
975
Drug Nomenclature
3.2K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.2K
Bioequivalence: Overview
1.8K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.8K
Dose-Response Relationship: Potency and Efficacy
6.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.3K


